BioNTech

#AstraZeneca #BioNTech #Covid-19 #Pfizer

Covid-19 vaccines remain effective six months after second dose

Two doses of Covid-19 vaccines were sufficient in providing protection against severe cases of the infectious disease, according to new research.  A study1 led by researchers at the University of Bristol found that two doses of Pfizer-BioNTech and AstraZeneca Covid-19 vaccines provided protection against Covid-19 infections six months… Read More

#Covid-19 #News

#BioNTech #Covid-19 #CureVac #mRNA #Pfizer

CureVac lawsuit against BioNTech over Covid-19 vaccine technology  

Biopharmaceutical company CureVac has filed a lawsuit against BioNTech SE and two of its subsidiaries in relation to an alleged infringement of the company’s portfolio used in the manufacture and sale of the Comirnaty Covid-19 vaccine.  CureVac has filed the lawsuit in the German Regional Court in… Read More

#News